2026 NPPES data Hematology & Oncology Physician NPI 1659607844 D.O
Verify on CMS →

CHRISTINE SARACENI, D.O

Hematology & Oncology Physician in AVONDALE, Arizona. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 243 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
77%
generic claims · 23% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
97.4263/100
▲ 14 pts above national avg 83.1 · [object Object]
Industry payments
$4.8K
175 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

CHRISTINE SARACENI, D.O reported a CMS MIPS final score of 97.4263/100 — above the 83.1 national average — and filed 1,452 Medicare Part D claims in 2023.

97.4263/100
MIPS score · +14 vs avg
1K
Part D claims, 2023
77%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

CHRISTINE SARACENI, D.O's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

97 Top 15% higher than 85% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

CHRISTINE SARACENI, D.O practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about CHRISTINE SARACENI, D.O?

High performer (top quartile)

NPI registry status

Active

Issued 10/23/2009

NPI 1659607844

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

1,452 71% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

97.4263/100 14.326300000000003% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Arizona

How Hematology & Oncology Physician compares to other specialties among Arizona providers

Arizona providers

Hematology & Oncology Physician share within Arizona

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Arizona

Medicare quality performance — MIPS

CHRISTINE SARACENI, D.O's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

High performer (top quartile)
MIPS Final Score
97.4263/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 97.4263/100 vs national avg 83.1

0%100%National avg83%97.4%
MIPS final score (Hematology & Oncology Physician) — 97.4263/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

CHRISTINE SARACENI, D.O appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding D.O credentials at 13055 W MCDOWELL RD STE G112, AVONDALE, AZ, 85392, with a listed phone of (623) 312-3020. NPI 1659607844 was issued on 10/23/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SARACENI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,452 prescription claims written by this provider, covering 243 Medicare beneficiaries and totaling roughly $2.2 million in drug spend, split 23% brand-name and 77% generic by claim count, with an opioid prescribing rate of 5.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 97.4263/100 for the 2023 performance year (Quality 97.7977), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

13055 W MCDOWELL RD STE G112
AVONDALE, AZ 85392

Provider Details

NPI 1659607844
Specialty Hematology & Oncology Physician
Credentials D.O
Gender Female
NPI Issued 10/23/2009

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

97.4263
Final Score
Avg: 83.1
97.7977
Quality
85
Promoting Interoperability

Reporting: Individual

Hospital and facility affiliations

Facilities where CHRISTINE SARACENI, D.O bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

IRONWOOD PHYSICIANS PC
GLENDALE, AZ

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for CHRISTINE SARACENI, D.O. Source: openpaymentsdata.cms.gov.

Total received

$4.8K

Largest payer

Novartis Pharmaceuticals Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

CHRISTINE SARACENI, D.O — brand share 23.0%
Specialty average (est.)

23% brand-name claims vs 77% generic, on 1,452 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,452
Total Claims
$2.2M
Total Drug Cost
243
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,319
Total Day Supply
61,188
Brand vs Generic
23% brand / 77% generic
Brand Drug Cost
$1.9M
Generic Drug Cost
$304K
Opioid Claims
78 (5.4% rate)
Antibiotic Claims
45

Patient Demographics

Average Patient Age
72.9 years
Avg HCC Risk Score
2.08
Gender Split
70% female / 30% male
Age Distribution
<65: 21, 65-74: 121, 75-84: 77, 85+: 24

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What CHRISTINE SARACENI, D.O prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Eliquis
Apixaban
204
Letrozole
147
Anastrozole
90
Ondansetron Odt
Ondansetron
67
Prochlorperazine Maleate
67
Hydroxyurea
64
Dexamethasone
57
Acyclovir
49
Oxycodone Hcl
48
Gabapentin
46

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How CHRISTINE SARACENI, D.O fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

CHRISTINE SARACENI, D.O's 1,452 claims are above the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Arizona

Other clinicians with the same primary specialty enrolled in Arizona, drawn from the same CMS NPPES roster as SARACENI.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is CHRISTINE SARACENI, D.O's specialty?
CHRISTINE SARACENI, D.O specializes in Hematology & Oncology Physician and practices in AVONDALE, Arizona. Credentials: D.O.
How much does CHRISTINE SARACENI, D.O prescribe under Medicare Part D?
In 2023, CHRISTINE SARACENI, D.O wrote 1,452 Medicare Part D claims totaling $2.2M in drug costs for 243 beneficiaries.
What is CHRISTINE SARACENI, D.O's Medicare quality score?
CHRISTINE SARACENI, D.O has a CMS MIPS Final Score of 97.4263/100 (Quality: 97.7977). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is CHRISTINE SARACENI, D.O located?
CHRISTINE SARACENI, D.O is located at 13055 W MCDOWELL RD STE G112, AVONDALE, AZ, 85392. Phone: (623) 312-3020.
What is CHRISTINE SARACENI, D.O's NPI number?
CHRISTINE SARACENI, D.O's National Provider Identifier (NPI) is 1659607844, issued on 10/23/2009.
Does CHRISTINE SARACENI, D.O prescribe more brand-name or generic drugs?
CHRISTINE SARACENI, D.O's prescribing is 23% brand-name and 77% generic drugs by claim count, with $1.9M in brand drug costs.
Does CHRISTINE SARACENI, D.O prescribe opioids?
Yes, CHRISTINE SARACENI, D.O had 78 opioid claims in 2023 with an opioid prescribing rate of 5.4%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does CHRISTINE SARACENI, D.O prescribe most often?
Based on 2023 Medicare Part D data, CHRISTINE SARACENI, D.O's most frequently prescribed drugs include Eliquis, Letrozole, Anastrozole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does CHRISTINE SARACENI, D.O accept Medicare?
CHRISTINE SARACENI, D.O appears in CMS Medicare data with 1,452 Part D claims and 243 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify CHRISTINE SARACENI, D.O's credentials?
CHRISTINE SARACENI, D.O's NPI is 1659607844 with credentials D.O. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology